Acid Sphingomyelinase Deficiency (ASMD) Overview

Save information for later
Sign Up

Learn About Acid Sphingomyelinase Deficiency (ASMD)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Acid Sphingomyelinase Deficiency (ASMD) Local Doctors?
Elite in Acid Sphingomyelinase Deficiency (ASMD)
Medical Genetics | Pediatrics
Elite in Acid Sphingomyelinase Deficiency (ASMD)
Medical Genetics | Pediatrics

Montefiore Medical Center

111 E 210th St, 
Bronx, NY 
Languages Spoken:
English

Melissa Wasserstein is a Medical Genetics specialist and a Pediatrics provider in Bronx, New York. Dr. Wasserstein and is rated as an Elite provider by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). Her top areas of expertise are Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Reticulohistiocytoma, and Splenomegaly.

Elite in Acid Sphingomyelinase Deficiency (ASMD)
Elite in Acid Sphingomyelinase Deficiency (ASMD)
Hochheim, TH, DE 

Eugen Mengel practices in Hochheim, Germany. Mr. Mengel and is rated as an Elite expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). His top areas of expertise are Niemann-Pick Disease, Acid Sphingomyelinase Deficiency (ASMD), Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Acid Sphingomyelinase Deficiency (ASMD)
Elite in Acid Sphingomyelinase Deficiency (ASMD)
Paris, FR 

Olivier Lidove practices in Paris, France. Mr. Lidove and is rated as an Elite expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). His top areas of expertise are Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Fabry Disease, Splenectomy, and Kidney Transplant.

What are the latest Acid Sphingomyelinase Deficiency (ASMD) Clinical Trials?
A Prospective Observational Study to Assess the Long-term Safety and Immunogenicity of Olipudase Alfa Therapy During Routine Clinical Care in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency

Summary: US, multicenter, cohort, open label observational study with primary data collection. Ancillary protocol-specified procedures to address the study objectives (eg, assessment of ADA) may be considered outside the standard of care for acid sphingomyelinase deficiency (ASMD), but the study methodology remains non-interventional, as the additional collection of data from participants will not dictate ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Longitudinal Study of Neurodegenerative Disorders

Summary: The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.